Table 2.
Phytochemicals or Extracts | Potential Antiviral Activity | Delivery System Strategy | Reference |
---|---|---|---|
Myricetin | HIV, RLV, influenza | Self-nanoemulsifying drug delivery systems SNEDDS, nanogel, mixed micelles, cocrystal, nanoencapsulation, nanosuspension |
[155] |
Apigenin | Influenza A, HCV, Enterovirus 71, FMDV, ASFV. | Solid dispersion, W/O/Wemulsion, O/W microemulsion, mixed micelles, phospholipid phytosome, self-microemulsifying drug delivery systems (SMEDDS) pellets | [156,157,158] |
Baicalin | DENV, RSV, HIV, Hepatitis B virus (HBV), influenza virus, NDV, enterovirus 71. | Liposome, mixed micelles, polymeric micelles, SNEDDS, SMEDDS, nanoparticles, nanocrystals, inclusion complex solid dispersion |
[159,160] |
Catechins | HBV, HSV, EBV, Adenovirus, HIV, HCV, Influenza virus, DENV, JEV, TBEV Zika Virus (ZIKV), CHIKV, HTLV-1, Rotavirus, Enterovirus EV71, EBOV, PRRSV, VHSV, IHNV, SVCV, GCRV. | Microparticles, calcium pectinate gel particles, chitosan nanoparticles, Nanoparticles of Polylactic Acid–polyethylene Glycol, poly(lactic-co-glycolic acid) nanoparticles, gold nanoparticles, colloidal complexes, liposomes, nanoemulsions | [161,162] |
Hydroalcoholic extracts from Forsythiae fructus rich in Forsythoside A; Phillyrin; Calceolarioside; Rengynic acid | Influenza, RSV | Chito-oligosaccharides | [163] |
Extracts from Forsythiae fructus rich in 3,5-dicaffeoylquinic acid, 3,4-dicaffeoylquinic acid, neochlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isoforsythoside, forsythoside A, forsythoside B | Influenza, RSV, HIV, NDV | Chito-oligosaccharides | [164] |
Andrographolide | DENV, CHIKV, HBV, HCV, HSV1, EBV, HIV HPV16, pseudovirus, influenza. |
Microspheres; nanosuspension and self-nanodispersion; nanoparticles, SMEDDS, inclusion complex |
[165,165] |
Anthocyanin-rich extracts (from Mulberry) and purified compounds (i.e., delphinidin, cyanidin, and pelargonidin) | Influenza virus, HSV type 1 and 2, RV, Adenovirus 36, BT2, T4 and simian rotavirus SA-11, HAV, FCV-F9 and MNV-1, HCV, WNV, DENV, and ZIKV. | Micro/nanoencapsulation systems, nano/micro-gels, spray-drying and freeze-drying, electrohydrodynamic encapsulation, emulsification and liposomal encapsulation | [166,167,168] [169] |
Curcumin | ZIKV, CHIKV, norovirus, Influenza, DENV type 2, RSV, HBV, HCV, HPV, HIV, CMV, EV71. |
Nanoparticles, solid dispersion, SNEDDS, SMEDDS, lipid carrier, copolymeric and mixed micelles, exosomes | [170,171] |
Water extract from Panax ginseng root and punicalagin | HSV types 1 and 2 | Hydroxypropyl methylcellulose (HPMC) hydrogel | [172,173] |
Water extract from Panax ginseng root and punicalagin | Influenza A virus (strain A/PR/8) | Ultra-sonication-assisted silver nanoparticles | [172,173] |
Hydroalcoholic extract from Elderberry and Eucalyptus | Influenza virus | Oil-in-water (o/w) and water-in-oil (w/o) emulsions | [174,175] |
Hydroalcoholic extract from Elderberry and Eucalyptus | Common cold | Encapsulation (BerryPharma® brand) |
[174,175] |
Coumestrol | HSV types 1 and 2 | Lipid nanoemulsion based on dioleylphosphocholine | [176] |
Quercetin | JEV, influenza A, EBV, MAYV, RV, HCV | Nanocrystal, nanoparticles phytosome, nanoliposome, mixed micelles, SNEDDS, nanocarrier, nanoemulsion, nanosuspension | [177,178] |
Naringenin | DENV, HCV | SNEDDS, solid dispersion, nanoparticles, liposome, nanosuspension, cyclodextrin complex | [178,179,180] |
Resveratrol | HIV/AIDS | Polymeric nanoparticles, solid-liquid nanoparticles, self-emulsifying methods, nanosponges, liposomes, emulsion-liposome blends, lipid-core nanocapsules, active lipospheres | [179,180] |
Silibinin | Hepatitis C virus infection | Encapsulation based on phytoliposomes | [181] |